Program in Ethics and Brain Sciences

The Johns Hopkins Berman Institute of Bioethics Neuroethics Program, the Program in Ethics and Brain Sciences (PEBS), represents the first formal collaboration between the Johns Hopkins Berman Institute of Bioethics and the Johns Hopkins Brain Sciences Institute. The goal of PEBS is to ensure that research in brain science proceeds with an informed and sophisticated understanding of attendant ethical and social issues, and that philosophical and empirical analysis of the advances in brain research proceeds with an informed and sophisticated understanding of the science.

Founded in 2003, PEBS is currently focusing on concepts that are critical to understanding the moral dimensions of scientific advances in our understanding of the brain and the clinical management of disease and injury therein, such as—personal identity, moral responsibility and free will, and the meaning of the neural basis of morality. Past projects include a consensus conference that gathered key stakeholders to discuss the scientific and ethical challenges associated with deep brain stimulation for disorders of mood, behavior and thought. PEBS is an interdisciplinary endeavor, both in subject and in membership. Group discussion ranges from moral philosophy to novel therapeutic approaches to disease and from public policy to basic science.



  • Marilyn Albert, Ph.D., Professor, Neurology and Psychiatry & Behavioral Sciences; Director, Division of Cognitive Neurosciences
  • Brian S. Appleby, M.D., Fellow, Geriatric Psychiatry
  • Ted M. Dawson, M.D. Ph.D., Professor, Neurology and Neuroscience
  • J. Raymond DePaulo, M.D., Henry Phipps Professor of Psychiatry & Behavioral Sciences; Director and Psychiatrist-in-Chief, Department of Psychiatry & Behavioral Sciences
  • Ruth R. Faden, Ph.D., M.P.H., Philip Franklin Wagley Professor of Biomedical Ethics; Professor, Health Policy & Management; Director, Berman Institute John Freeman, M.D., Professor, Neurology and Pediatrics; Director, Pediatric Epilepsy Center; Core Faculty, Berman Institute
  • Michela Gallagher, Ph.D., Krieger-Eisenhower Professor; Professor, Psychology and Neuroscience; Chair, Department of Psychological & Brain Sciences
  • Gail Geller, Sc.D., Professor, Pediatrics and Health Policy & Management; Core Faculty, Berman Institute
  • John W. Griffin, M.D., Professor, Neurology, Neuroscience, and Pathology; Director and Neurologist-in-Chief, Department of Neurology
  • Kay Jamison, Ph.D., Professor, Psychiatry & Behavioral Sciences
  • Richard Johnson, M.D., Professor, Neurology, Molecular Biology & Genetics, and Neuroscience
  • Paul McHugh, M.D., Henry Phipps Professor of Psychiatry; Chair Psychiatry and Behavioral Sciences; Professor of Mental Hygiene
  • Guy M. McKhann, M.D., Professor, Neurology; Professor, Neuroscience; Director Zanvyl Krieger Mind-Brain Institute
  • Alan Regenberg, M.Be., Senior Research Program Coordinator, Berman Institute
  • Christopher A. Ross, M.D, Ph.D., Professor, Psychiatry; Professor, Neurology; Professor, Neuroscience; Director, Division of Neurobiology
  • Andrew Siegel, J.D., Ph.D., Assistant Professor of Obstetrics and Gynecology; Assistant Scientist, Health Policy and Management; Core Faculty, Berman Institute

Affiliate Members

  • Solomon Snyder, M.D., D.Sc., D.Phil., Professor, Neuroscience, Psychiatry & Behavioral Sciences, and Pharmacology & Molecular Sciences; Director, Department of Neuroscience
  • Meredith Williams, Ph.D., Professor, Philosophy


  • Personal Identity Symposium Working Group on Interspecific Chimeric Brains Neurotherapeutics
  • Working Group on Human Trials of Cell-Based Interventions for Neurological Conditions
  • Deep Brain Stimulation for Disorders of Mood, Behavior and Thought: Scientific and Ethical Issues
  • Free Will and Moral Responsibility: Implications of Advances in Neuroscience

PEBS Contact

Alan Regenberg
1809 Ashland Ave.
Baltimore, MD 21205